Hikma Pharmaceuticals Plc (HKMPF)
19.29
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Hikma Pharmaceuticals Market Cap
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| May 27, 2026 | 4.329B |
| May 26, 2026 | 4.329B |
| May 22, 2026 | 4.145B |
| May 21, 2026 | 4.145B |
| May 20, 2026 | 4.145B |
| May 19, 2026 | 4.145B |
| May 18, 2026 | 4.232B |
| May 15, 2026 | 4.232B |
| May 14, 2026 | 4.210B |
| May 13, 2026 | 4.210B |
| May 12, 2026 | 4.210B |
| May 11, 2026 | 4.189B |
| May 08, 2026 | 4.175B |
| May 07, 2026 | 4.175B |
| May 06, 2026 | 4.175B |
| May 05, 2026 | 4.175B |
| May 04, 2026 | 3.928B |
| May 01, 2026 | 3.928B |
| April 30, 2026 | 3.928B |
| April 29, 2026 | 3.928B |
| April 28, 2026 | 3.928B |
| April 27, 2026 | 3.928B |
| April 24, 2026 | 3.928B |
| April 23, 2026 | 3.928B |
| April 22, 2026 | 3.928B |
| Date | Value |
|---|---|
| April 21, 2026 | 4.062B |
| April 20, 2026 | 4.062B |
| April 17, 2026 | 4.062B |
| April 16, 2026 | 3.930B |
| April 15, 2026 | 3.907B |
| April 14, 2026 | 3.907B |
| April 13, 2026 | 3.754B |
| April 10, 2026 | 3.754B |
| April 09, 2026 | 3.754B |
| April 08, 2026 | 3.754B |
| April 07, 2026 | 3.754B |
| April 06, 2026 | 3.754B |
| April 02, 2026 | 3.754B |
| April 01, 2026 | 3.754B |
| March 31, 2026 | 3.754B |
| March 30, 2026 | 3.754B |
| March 27, 2026 | 3.754B |
| March 26, 2026 | 3.754B |
| March 25, 2026 | 3.754B |
| March 24, 2026 | 3.754B |
| March 23, 2026 | 3.754B |
| March 20, 2026 | 3.754B |
| March 19, 2026 | 3.767B |
| March 18, 2026 | 3.767B |
| March 17, 2026 | 3.767B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 555.07B |
| GSK Plc | 102.85B |
| Allergy Therapeutics Plc | -- |
| Shield Therapeutics Plc | -- |
| Futura Medical Plc | -- |
Market Cap Related Metrics
| PE Ratio | 10.63 |
| PS Ratio | 1.274 |
| PEG Ratio | 0.0945 |
| Price to Free Cash Flow | 101.63 |
| Price | 19.29 |
| Earnings Yield | 9.41% |
| PEGY Ratio | 0.091 |
| Operating PE Ratio | 7.515 |
| Normalized PE Ratio | 11.50 |